Works matching IS 00302414 AND DT 2021 AND VI 99


Results: 107
    1
    2

    Contents Volume.

    Published in:
    Oncology, 2021, v. 99, n. 12, p. I, doi. 10.1159/000520631
    Publication type:
    Article
    3

    Front & Back Matter.

    Published in:
    Oncology, 2021, v. 99, n. 12, p. 1, doi. 10.1159/000521091
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    Front & Back Matter.

    Published in:
    Oncology, 2021, v. 99, n. 11, p. 1, doi. 10.1159/000520576
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Front & Back Matter.

    Published in:
    Oncology, 2021, v. 99, n. 10, p. 1, doi. 10.1159/000519738
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Pretreatment Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment.

    Published in:
    Oncology, 2021, v. 99, n. 10, p. 611, doi. 10.1159/000516565
    By:
    • Kawamura, Yusuke;
    • Kobayashi, Masahiro;
    • Shindoh, Junichi;
    • Kobayashi, Yuta;
    • Okubo, Satoshi;
    • Muraishi, Nozomu;
    • Iritani, Soichi;
    • Fujiyama, Shunichiro;
    • Hosaka, Tetsuya;
    • Saitoh, Satoshi;
    • Sezaki, Hitomi;
    • Akuta, Norio;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Ikeda, Kenji;
    • Arase, Yasuji;
    • Hashimoto, Masaji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    28

    Front & Back Matter.

    Published in:
    Oncology, 2021, v. 99, n. 8, p. 1, doi. 10.1159/000518759
    Publication type:
    Article
    29
    30

    Front & Back Matter.

    Published in:
    Oncology, 2021, v. 99, n. 9, p. 1, doi. 10.1159/000519249
    Publication type:
    Article
    31

    First Report of Oncological Outcome and Prognostic Analysis in a First-Line Setting of Short Hydration Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Urothelial Carcinoma.

    Published in:
    Oncology, 2021, v. 99, n. 10, p. 622, doi. 10.1159/000517326
    By:
    • Naiki, Taku;
    • Nagai, Takashi;
    • Sugiyama, Yosuke;
    • Etani, Toshiki;
    • Nozaki, Satoshi;
    • Iida, Keitaro;
    • Noda, Yusuke;
    • Shimizu, Nobuhiko;
    • Isobe, Teruki;
    • Matsumoto, Daisuke;
    • Kubota, Hiroki;
    • Hamamoto, Shuzo;
    • Ando, Ryosuke;
    • Kawai, Noriyasu;
    • Yasui, Takahiro
    Publication type:
    Article
    32

    Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

    Published in:
    Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Michitaka, Kojiro;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Fukunishi, Shinya;
    • Ohama, Hideko;
    • Kawata, Kazuhito
    Publication type:
    Article
    33
    34

    Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

    Published in:
    Oncology, 2021, v. 99, n. 9, p. 562, doi. 10.1159/000516745
    By:
    • Imai, Hisao;
    • Kishikawa, Takayuki;
    • Minemura, Hiroyuki;
    • Yamada, Yutaka;
    • Ibe, Tatsuya;
    • Mori, Keita;
    • Yamaguchi, Ou;
    • Mouri, Atsuto;
    • Hamamoto, Yoichiro;
    • Kanazawa, Kenya;
    • Kasai, Takashi;
    • Kaira, Kyoichi;
    • Kaburagi, Takayuki;
    • Minato, Koichi;
    • Kobayashi, Kunihiko;
    • Kagamu, Hiroshi
    Publication type:
    Article
    35
    36
    37
    38

    Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.

    Published in:
    Oncology, 2021, v. 99, n. 8, p. 507, doi. 10.1159/000515865
    By:
    • Ando, Yuwa;
    • Kawaoka, Tomokazu;
    • Amioka, Kei;
    • Naruto, Kensuke;
    • Ogawa, Yutaro;
    • Yoshikawa, Yuki;
    • Kikukawa, Chihiro;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Morio, Kei;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Yamauchi, Masami;
    • Tsuge, Masataka;
    • Hiramatsu, Akira;
    • Fukuhara, Takayuki;
    • Mori, Nami;
    • Takaki, Shintaro;
    • Tsuji, Keiji
    Publication type:
    Article
    39
    40

    BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.

    Published in:
    Oncology, 2021, v. 99, n. 9, p. 580, doi. 10.1159/000516168
    By:
    • Vassilakopoulou, Maria;
    • Won, Minhee;
    • Curran, Walter J.;
    • Souhami, Luis;
    • Prados, Michael D.;
    • Langer, Corey J.;
    • Rimm, David L.;
    • Hanna, Jason A.;
    • Neumeister, Veronique M.;
    • Melian, Edward;
    • Diaz, Aidnag Z.;
    • Atkins, James N.;
    • Komarnicky, Lydia T.;
    • Schultz, Christopher J.;
    • Howard, Steven P.;
    • Zhang, Peixin;
    • Dicker, Adam P.;
    • Knisely, Jonathan P.S.
    Publication type:
    Article
    41
    42

    Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.

    Published in:
    Oncology, 2021, v. 99, n. 8, p. 491, doi. 10.1159/000515280
    By:
    • Naruto, Kensuke;
    • Kawaoka, Tomokazu;
    • Amioka, Kei;
    • Ogawa, Yutaro;
    • Chihiro, Kikukawa;
    • Yoshikawa, Yuki;
    • Ando, Yuwa;
    • Suehiro, Yosuke;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Kodama, Kenichiro;
    • Morio, Kei;
    • Fujino, Hatsue;
    • Murakami, Eisuke;
    • Nakahara, Takashi;
    • Yamauchi, Masami;
    • Tsuge, Masataka;
    • Hiramatsu, Akira;
    • Fukuhara, Takayuki;
    • Takaki, Shintaro
    Publication type:
    Article
    43
    44

    Front & Back Matter.

    Published in:
    Oncology, 2021, v. 99, n. 7, p. 1, doi. 10.1159/000517984
    Publication type:
    Article
    45
    46
    47
    48
    49
    50